相关实验视频

Updated: Jan 10, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

设计的强效DC疫苗使DC-T细胞接触得更紧密,从而触发个性化的抗瘤免疫

Ying Sun¹, Jialin Sun², Qie Guo²

¹Department of Health Management Center, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.

Journal of controlled release : official journal of the Controlled Release Society

|November 20, 2025

概括

这项研究开发了一种新的树突细胞 (DC) 疫苗平台,使用纳米规模的抗原递送来增强抗瘤免疫反应. 强大的DC疫苗有效地抑制了小鼠的瘤复发和转移,提供了一个有前途的癌症免疫治疗策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

个性化树突细胞 (DC) 疫苗在术后癌症治疗中表现有前途.
目前的直流疫苗由于T细胞激活不足和信号传导受损,有效性有限.
需要改进的策略来提高DC疫苗的效力和临床结果.

研究的目的:

开发一个新的,强大的DC疫苗平台,整合纳米级抗原输送和合成免疫学.
增强DC介导抗原呈现和DC-T细胞相互作用,以改善抗瘤免疫力.
在临床前癌症模型中评估新型DC疫苗的治疗疗效.

主要方法:

集成的纳米级抗原输送与合成免疫学方法,以创建强大的DC疫苗.
设计了DC疫苗,通过MHC I类分子交叉呈现瘤抗原.
利用表面固定的抗CD3抗体来增强DC-T细胞接触和信号传输.

主要成果:

新型DC疫苗在给药后有效地迁移到淋巴结.
在小鼠中表现出优异的抗瘤免疫激活和显著的治疗疗效,抑制剩余瘤复发和转移.
与PD-1抗体的联合治疗进一步延长了治疗小鼠的生存时间.

结论:

建立了一个创新的DC疫苗平台,强调抗原呈现和DC-T细胞接触在抗瘤免疫中的重要性.
开发的DC疫苗提供了一个翻译解决方案,以克服癌症免疫治疗当前的局限性.
这一策略有可能改善术后辅助癌症治疗和患者的治疗结果.

关键词:

抗原交叉呈现的交叉呈现反瘤免疫力抗瘤免疫力 DC-T 电池的接触方式代谢细胞标记的标签强大的DC疫苗DC疫苗

更多相关视频

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...